Pharmacologic immunosuppressive therapy and extracorporeal immunoadsorption in the suppression of anti-αGal antibody in the baboon

Xenotransplantation

Volumn 5, Issue 4, 1998, Pages 274-283

  Lambrigts, Denis ^a,c   Van Calster, Pascale ^a   Xu, Yuanxin ^b   Awwad, Michel ^b   Neethling, Francisca A ^a   Kozlowski, Tomasz ^a   Foley, Alicia ^b   Watts, Alan ^b   Chae, Sanders J ^a   Fishman, Jay ^a   Thall, Aron D ^b   White Scharf, Mary E ^b   Sachs, David H ^a   Cooper, David K C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BioTransplant Inc   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Anti Gal antibody; Antibody immunoadsorption; Baboon; Pharmacologic immunosuppression

Indexed keywords

BREQUINAR; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; MELPHALAN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; THYMOCYTE ANTIBODY;

ANIMAL MODEL; ARTICLE; BABOON; CYTOTOXICITY; GRAFT REJECTION; IMMUNOADSORPTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INTRAGASTRIC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; NONHUMAN; PRIORITY JOURNAL; XENOTRANSPLANTATION;

EID: 0032414777     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1998.tb00038.x     Document Type: Article

References (52)

1. GOOD H, COOPER DKC, MALCOLM AJ, et al. Identification of carbohydrate structures which bind human anti-porcine antibodies: Implications for discordant xenografting in man. Transplant Proc 1992; 24:559.
2. COOPER DKC, GOOD AH, KOREN E, et al. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: Relevance to discordant xenografting in man. Transplant Immunol 1993; 1:198.
3. SANDRIN MS, VAUGHAN HA, DABKOWSKI PL, MCKENZIE IFC. Anti-pig IgM antibodies in human serum react predominantly with Gal(α1-3)Gal epitopes. Proc Natl Acad Sci USA 1993; 90:11391.
4. GALILI U. Interaction of the natural anti-Ga al. Evidence that intravenously administrated α-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 1994; 58:330.
5. ORIOL R, YE Y, KOREN E, COOPER DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56:1433.
6. NEETHLING FA, KOREN E, YE Y, et al. Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by α-galactosyl oligosaccharides. Transplantation. 1994; 57:959.
7. TANIGUCHI S, NEETHLING FA, KORCHAGINA EY, et al. In vivo immunoadsorption of anti-pig antibodies in baboons using a specific Galal-3Gal column. Transplantation 1996; 62:10.
8. YE Y, NEETHLING FA, NIEKRASZ M, et al. Evidence that intravenously administrated α-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidneys cells (PK15) and transplanted pig hearts. Transplantation 1994; 58:330.
9. COOPER DKC, CAIRNS TDH, TAUBE DH. Extracorporeal immunoadsorption of αGal antibodies. Xeno 1996; 4:2.
10. XU Y, LORF T, SABLINSKI T, et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Gala1-3βGal1-4βGlc-X immunoaffinity column. Transplantation 1998; 65:172.
11. KOZLOWSKI T, IERINO F, FUCHIMOTO Y, et al. Depletion of anti-Galα1-3Gal antibody in baboons by specific immunoaffinity columns. Xenotransplantation 1998; 5:122
12. ROSE AG, COOPER DKC. A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection. J Heart Lung Transplant 1996; 15:804.
13. KOBAYASHI T, TANIGUCHI S, NEETHLING FA, et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants following cobra venom factor. Transplantation 1997; 64:1255.
14. MOSES RD, AUCHINCLOSS H. Mechanisms of cellular xenograft rejection. In: Cooper DKC, et al., eds. Xenotransplantation, Second edition. Heidelberg: Springer, 1997, p 140.
15. SACHS DH, SYKES M, GREENSTEIN JL, COSIMI AB. Tolerance and xenograft survival. Nature Med 1995; 1:969.
16. KAWAI T, COSIMI B, COLVIN R, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59:2561.
17. SYKES M. Hematopoietic cell transplantation for the induction of allo and xenotolerance. Clin Transplantation 1996; 10:357.
18. BENSINGER WI, BAKER DA, BUCKNER CD, CLIFT RA, THOMAS ED. Immunoadsorption for removal of A and B blood group antibodies. N Engl J Med 1981; 304:1360.
19. ALEXANDRE GP, SQUIFFLET JP, DE BRUYERE M, et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 1985; 17:138.
20. BANNETT AD, MCALACK RF, RAJA R, BAQUERO A, MORRIS M. Experiences with known ABO-mismatched renal transplants. Transplant Proc 1987; 19:4543.
21. COOPER DKC, YE Y, NIEKRASZ M, et al. Specific intravenous carbohydrate therapy: A new concept in inhibiting antibody-mediated rejection: Experience with ABO-incompatible cardiac allografting in the baboon. Transplantation 1993; 56:769.
22. BACH FH, TURMAN MA, VERCELLOTTI GM, PLATT JL, DALMASSO AP. Accommodation: A working paradigm for progressing toward clinical discordant xenografting. Transplant Proc 1991; 23:205.
23. LATINNE D, GIANELLO P, SMITH CV, et al. Xenotransplantation from pig to cynomolgus monkey: Approach toward tolerance induction. Transplant Proc 1993; 25:336.
24. TANAKA M, LATINNE D, GIANELLO P, et al. Xenotransplantation from pig to cynomolgus monkey: The potential for overcoming xenograft rejection through induction of chimerism. Transplant Proc 1994; 26:1326.
25. SABLINSKI T, LATINNE D, GIANELLO P, et al. Xenotransplantation of pig kidneys to nonhuman primates. I. Development of the model. Xenotransplantation 1995; 2:264.
26. BARTHOLOMEW A, COSIMI AB, SACHS DH, et al. A study of tolerance in a concordant xenograft model. Transplant Proc 1997; 29:923.
27. SACHS DH, SABLINSKI T. Tolerance across discordant xenogeneic barriers. Xenotransplantation 1995; 2:234.
28. SABLINSKI T, GIANELLO P, BAILIN M, et al. Pig-to-monkey bone marrow and kidney transplantation. Surgery 1997; 121:381.
29. COOPER DKC, YE Y, NIEKRASZ M. Heart transplantation in primates. In: Cramer DV, Podesta L, Makowka L, eds. Handbook of Animal Models in Transplantation Research. Boca Raton, CRC, 1993, p 173.
30. KOREN E, NEETHLING FA, KOSCEC M, et al. In vitro model for hyperacute rejection of xenogeneic cells. Transplant Proc 1994; 26:1166.
31. STARK JH, SMIT JA, GRIDELLI B. Sensitivity of baboon lymphocytes to cyclosporine A and FK506: Relative resistance of alloactivated cells to CyA. Transplant Int 1994; 7:372.
32. BERTINO JR Chemical action and pharmacology of methotrexate, azathioprine, and cyclophosphamide in man. Arthritis Rheum 1973; 16:79.
33. WAGONER LE, TAYLOR DO, OLSEN SL, et al. Cyclophosphamide in cardiac transplant recipients with frequent rejection: A six-year retrospective review. Clin Transplantation 1996; 10:437.
34. CRAMER DV, CHAPMAN FA, JAFFEE BD, et al. The effect of new immunosuppressive drug, brequinar sodium, on concordant hamster-to-rat cardiac xenografts. Transplant Proc 1992; 24:720.
35. YASUNAGA C, CRAMER DV, COSENZA CA, et al. Effect of brequinar sodium on in vivo antibody production. Transplant Proc 1993; 25:40.
36. BRAZELTON TR, CHEUNG A, MORRIS RE. Pharmacologic immunosuppressants in transplantation. In: Cooper, DKC, et al., eds. Xenotransplantation. Heidelberg: Springer, 1997, p 602.
37. MORRIS RE, HOYT G. Prolongation of rat heart allograft survival by RS-61443. Surg Forum 1989; 40:337.
38. MORRIS, RE WANG J. Immunosuppressive effects of the morphinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts. Transplant Proc 1991; 2:19.
39. OSSERMAN EF. Therapy of plasma cell myeloma with melphalan (1phenylalanine mustard). (Abstract) Proc Am Assoc Cancer Res 1963; 4:50.
40. HOOGSTRATEN B, SHEEHE PR, CUTTNER J, et al. Melphalan in multiple myeloma. Blood 1967; 30:74.
41. ALEXANIAN R, HAUT A, KHAN AU, et al. Treatment for multiple myeloma: Combination chemotherapy with different melphalan dose regimens. JAMA 1969; 208:1680.
42. KOZLOWSKI T, MONROY R, XU Y, et al. anti-Galα1-3 Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction. Transplantation 1998; 66:176.
43. MORSCHHEUSER T, STEINHOFF G, INDZHIIA L, HEISER A, HEIN M, LAPIN BA, HAVERICH A. Successful down-regulation of natural and xenoreactive antibodies in pig-to-baboon xenotransplantation by high-dose cyclophosphamide. Transplant Proc 1997; 29:970.
44. GALILI U, TIBELL A, SAMUELSSON B, RYDBERG L, GROTH CG. Anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Xenotransplantation 1995; 2:188.
45. GALILI U, LATEMPLE DC, WALGENBACH AW, STONE KR. Porcine and bovine cartilage transplants in cynomolgus monkeys. II. Changes in anti-gal response during chronic rejection. Transplantation 1997; 63:646.
46. KOZLOWSKI T, TIBELL A, MORPURGO E, et al. Suppression of immunoglobulin resynthesis after plasmapheresis: Efficacy of various immunosuppressive drugs: A study in rats. Transplant Proc 1995; 27:3545.
47. VAN DE STADT J, VENDEVILLE B, WEILL B, et al. Discordant heart xenografting in the rat: additional effect of phasma exchange and cyclosporine, cyclophosphamide, or splenectomy in delaying hyperacute rejection. Transplantation 1988; 45:514.
48. LEVENTHAL JR, FLORES HC, GRUBER SA, et al. Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation 1991; 54:26.
49. FIGUEROA J, FUAD SA, KUNJUMMEN BD, PLATT JL, BACH FH. Suppression of the synthesis of natural antibodies by mycophenolate mofetil (RS-61443): Its potential use in discordant xenografting. Transplantation 1993; 55:1371.
50. BLAKELY ML, VANDER WERF WJ, DALMASSO AP, BACH FH. Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts. Transplant Proc 1994; 26:1374.
51. LUCIEN J, MARATH A, RAYAT G, THLIVERIS J, KOSHAL A, YATSCOFF R. Efficacy of leflunomide to reduce xeno antibody titers in vivo: An evaluation of the prolongation of discordant xenograft survival. Transplant Proc 1996; 28:704.
52. BACH FH, ROBSON SC, WINKLER H, et al. Barriers to xenotransplantation. Nature Med 1996; 1:869.